Navigating New Treatment Options for COPD | Consultant360
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
Learn More Breathe Better - A long-acting muscarinic antagonist (LAMA) is a medicine that may help control asthma long-term. Download this fact sheet to learn more about LAMAs and how they're used:
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD) - Horita, N - 2017 | Cochrane Library
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Key findings of recent LAMA and dual-agent LAMA/LABA trials reviewed. | Download Table
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease - ScienceDirect
Understanding the role of long-acting muscarinic antagonists in asthma treatment - ScienceDirect
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
Aclidinium: A long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of COPD Stock Photo - Alamy
Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression - Yuji Oba, Nazir A. Lone, 2015
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar